Xortx Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.09

+0.06 (+2.96%)

As of Aug 8, 2:34 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +1,940.1% upside

Low Target $28.32

Average Target $42.64

High Target $47.79

Current Price $2.09

Current
$2.09

Target
$42.64

$28.32 $42.64 avg $47.79

Scenario Analysis

Bear Case

$28.32

1,255.0%

Low target

Base Case

$42.64

+1,940.1%

Avg target

Bull Case

$47.79

+2,186.5%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$9.85

-78.8% from high

52-Week Low

$2.42

+-13.6% from low

Target vs 52W High

$42.64

+332.9% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Sell	44	52%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%